DeborahAWingMDMBA

Obstetrics & Gynecology • Century City, CA

Maternal & Fetal Medicine/High Risk

Senior Client Partner, Academic Health Center Practice, Korn Ferry

Join to view full profile

Dr. Wing is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wing's full profile

Already have an account?

Office
Korn Ferry
1900 Avenue of the Stars, Suite 2600
Century City, CA 90067
Phone+1 310-843-4144

Summary

With a focus on securing top executives for academic health science centers, I bring contemporary industry knowledge with a focus on diversity to executive search and talent development assignments throughout the U.S. and Canada.

I am a former Professor of Obstetrics-Gynecology and MFM Division Director at the University of California, Irvine. There, with talented basic science colleagues I opened a Perinatal Research Laboratory, acquired nearly $8M in NIH-funding and trained fellows who assumed positions in academic institutions including Johns Hopkins University, Northwestern University and the University of Colorado. I am board-certified in obstetrics-gynecology and in the subspecialty of maternal-fetal medicine and have served as an examiner for the American Board of Obstetrics and Gynecology and on the Maternal-Fetal Medicine Subspecialty Division.

I am a proud member of the Society for Maternal-Fetal Medicine with service on many prominent committees related to research, finance and philanthropy, and also act as a consultant for several national and international biotechnology and pharmaceutical firms.

Education & Training

University of California, IrvineEMBA, Healthcare, 2013 - 2015
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Maternal-Fetal Medicine, 1993 - 1995
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 1989 - 1993
Tulane University School of MedicineClass of 1989
Pomona CollegeBA, Chemistry-biology, 1981 - 1985

Certifications & Licensure

CA State Medical License 1990 - 2026
LA State Medical License 1989 - 1990
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Cranberry Juice for Preventing Bacteria in Urine During Pregnancy Start of enrollment: 2004 Dec 01
Completed
Phase 1
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia Start of enrollment: 2006 Oct 01
Unknown status
Assessment of Activity in Pregnancy Using an Actigraph Start of enrollment: 2007 Jul 01
Withdrawn
Effectiveness of Cranberry Ingestion on Bacterial Adhesion: An Adjunct Study Start of enrollment: 2006 Aug 01
Completed
Not Applicable
Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics Start of enrollment: 2006 Mar 01
Terminated
Not Applicable
Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)
Withdrawn
Phase 2
Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia Start of enrollment: 2009 Mar 01
Unknown status
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery Start of enrollment: 2010 Sep 01
Completed
Phase 3
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be Start of enrollment: 2010 Sep 01
Completed
Increased Cefazolin During Cesarean Delivery in Obese Population Start of enrollment: 2013 Aug 01
Completed
Phase 4
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia Start of enrollment: 2014 Jul 11
Completed
Phase 3
nuMoM2b Heart Health Study Start of enrollment: 2014 Sep 01
Completed
Join now to see all

Publications & Presentations

PubMed

Corrigendum to 'Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length' Am J Obstet Gynec...
John Owen, Gary Hankins, Jay D Iams, Vincenzo Berghella, Jeanne S Sheffield
American Journal of Obstetrics and Gynecology. 2024-11-01
Fetal and Maternal Factors Predictive of Primary Cesarean Delivery at Term in a Low-Risk Population: NICHD Fetal Growth Studies-Singletons.
Julio Mateus, Danielle R Stevens, Katherine L Grantz, Cuilin Zhang, Jagteshwar Grewal
American Journal of Perinatology. 2024-07-29
Multiethnic growth standards for fetal body composition and organ volumes derived from 3D ultrasonography.
Katherine L Grantz, Wesley Lee, Lauren M Mack, Magdalena Sanz Cortes, Luis F Goncalves
American Journal of Obstetrics and Gynecology. 2024-06-03

Journal Articles

Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm P...
Michael J Paidas, George A Macones, Garrett K Lam, Everett F Magann, Erika F Werner, Mounira A Habli, Chad A Grotegut, Sherri A Longo, Erol Amon, William A Grobman, De..., American Journal of Obstetrics and Gynecology

Other

Prediction of Preterm Delivery in Symptomatic Women Using Placental Alpha‐Microglobulin‐1, Fetal Fibronectin and Phosphorylated Insulin‐like Growth Factor‐Binding Prot...
Deborah Wing, MD, Ultrasound in Obstetrics & Gynecology
https://www.doximity.com/articles/8f270847-6b98-4847-bbc5-787211182b42
UpToDate, Wolters Kluwer Health - 2013-04-01
Prediction of Preterm Delivery in Symptomatic Women Using Placental Alpha‐Microglobulin‐1, Fetal Fibronectin and Phosphorylated Insulin‐like Growth Factor‐Binding Prot...
Deborah Wing, MD, Ultrasound in Obstetrics & Gynecology
https://www.doximity.com/articles/8f270847-6b98-4847-bbc5-787211182b42
UpToDate, Wolters Kluwer Health - 2013-03-25
Prediction of Preterm Delivery in Symptomatic Women Using Placental Alpha‐Microglobulin‐1, Fetal Fibronectin and Phosphorylated Insulin‐like Growth Factor‐Binding Prot...
Deborah Wing, MD, Ultrasound in Obstetrics & Gynecology
https://www.doximity.com/articles/8f270847-6b98-4847-bbc5-787211182b42
UpToDate, Wolters Kluwer Health - 2013-04-04

Authored Content

Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)August 2020

Press Mentions

As Cases of Induced Labor Rise, so Do Experts' ConcernsJanuary 14th, 2003

Grant Support

Preterm Birth In Nulliparous Women: An Understudied Population At Great RiskEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
Cranberry For Prevention Of Bacteriuria In PregnancyNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005

Industry Relationships

Principal Investigator and Consultant, Parsogen2014 - Present
Consultant, Ferring Pharmaceuticals2005 - 2017

External Links

Korn Ferry Biosketchhttps://www.kornferry.com/consultants/deborahwing